Post-translational regulations of PD-L1/PD-1: Mechanisms and opportunities for combined immunotherapy.
Sign Up to like & getrecommendations! Published in 2021 at "Seminars in cancer biology"
DOI: 10.1016/j.semcancer.2021.04.002
Abstract: Antibodies targeting programmed cell death protein 1 (PD-1) or its ligand programmed death-ligand 1 (PD-L1) are profoundly changing the methods to treat cancers with long-term clinical benefits. Unlike conventional methods that directly target tumor cells,… read more here.
Keywords: opportunities combined; translational regulations; post translational; mechanisms opportunities ... See more keywords